DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,704,327 | +1145.5% | 18,665 | +1211.7% | 0.20% | +756.5% |
| Q4 2022 | $377,693 | -54.7% | 1,423 | -55.9% | 0.02% | -55.8% |
| Q3 2022 | $834,000 | -91.6% | 3,230 | -91.7% | 0.05% | -85.7% |
| Q2 2022 | $9,916,000 | +3613.9% | 39,114 | +4198.2% | 0.36% | +3530.0% |
| Q1 2022 | $267,000 | -97.7% | 910 | -97.4% | 0.01% | -98.1% |
| Q4 2021 | $11,671,000 | +2884.9% | 35,473 | +2660.5% | 0.52% | +2286.4% |
| Q3 2021 | $391,000 | +26.9% | 1,285 | +11.9% | 0.02% | +10.0% |
| Q2 2021 | $308,000 | -95.3% | 1,148 | -96.0% | 0.02% | -93.8% |
| Q1 2021 | $6,539,000 | -11.3% | 29,050 | -12.5% | 0.32% | +1.2% |
| Q4 2020 | $7,371,000 | +524.7% | 33,184 | +289.4% | 0.32% | +276.5% |
| Q1 2020 | $1,180,000 | -49.6% | 8,522 | -64.3% | 0.08% | -45.5% |
| Q1 2018 | $2,339,000 | +69.7% | 23,892 | +60.9% | 0.16% | +64.2% |
| Q4 2017 | $1,378,000 | -48.1% | 14,851 | -52.0% | 0.10% | -57.4% |
| Q3 2017 | $2,656,000 | -14.7% | 30,962 | -16.1% | 0.22% | -20.6% |
| Q2 2017 | $3,114,000 | +75.0% | 36,895 | +77.4% | 0.28% | +58.8% |
| Q1 2017 | $1,779,000 | -30.9% | 20,800 | -37.1% | 0.18% | -35.9% |
| Q4 2016 | $2,574,000 | +165.1% | 33,063 | +216.4% | 0.28% | +318.2% |
| Q4 2015 | $971,000 | -83.1% | 10,451 | -84.5% | 0.07% | -86.5% |
| Q3 2015 | $5,748,000 | +1875.3% | 67,458 | +1884.1% | 0.49% | +489.2% |
| Q4 2014 | $291,000 | – | 3,400 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |